Rwandan health authorities have taken swift action following safety concerns surrounding antifungal tablets produced in Kenya.
The Rwanda Food and Drugs Authority (RFDA) issued a recall notice for all batches of 200 mg Fluconazole tablets manufactured by the Kenyan company Universal Corporation.
The directive, aimed at importers, mandates the return of these tablets due to discolouration issues discovered by the RFDA.
Specifically, four bulk batches of pink Fluconazole 200mg tablets showed white discolouration shortly after their shelf life began once imported into Rwanda.
Highlighting the urgency of the situation, the RFDA emphasized that some of these discoloured tablets had already entered the Rwandan market.
Consequently, retailers and health facilities have been instructed to cease distribution and return the affected drugs immediately.
As a precautionary measure, health officials in Rwanda have launched an investigation to ascertain whether these potentially compromised drugs have caused any adverse effects among consumers.
Amid these developments, Kenyan authorities are yet to announce whether the same antifungal drug, commonly used to treat fungal or yeast infections, will also undergo a recall within the local market.
Read: Ned Nwoke: Nigerians Should Be Allowed to Carry Guns
About The Author
Related Articles
Tinubu Government Delays Release of Signed Tax Acts to the Public
Four days after President Bola Tinubu announced the signing of four tax...
As Tinubu Urges Africa-Caribbean Unity in Saint Lucia, Over 272 Nigerians Killed in June Alone
While Nigerians deal with deadly violence, worsening hunger, and mass flooding, President...
You Can’t Tax a Dead Economy: Nigeria Is Suffocating Under Its Own Policies
As Nigeria’s Central Bank clings to its benchmark interest rate of 27.5...
“Wike is Not a Blessing to Us, He’s a Disaster” — Workers Protest in Nigeria’s Capital Over Unpaid Wages, Poor Working Conditions
Staff members of the Federal Capital Territory Administration (FCTA) in Abuja barricaded...